business info

  • Musculoskeletal
  • Gastrointestinal (GI)
  • Cardiovascular (CV)
  • Urology
  • Antibiotics
  • Blood Preparetions
  • Vaccines
  • Parenteral Nutritions
  • Other Rx
HOME › Product info › Urology

Urology

mvix mvix
  • Mvix is a new PDE5 inhibitor developed by the Life Science R&D Center of SK chemical.
  • Mvix is an effective and well tolerated treatment for Korean men with ED of broad-spectrum etiology and severity
  • descriptin
    Mirodenafil HCl ------------------ 56.9mg, 113.8mg / Tab.(Mirodenafil 50mg, 100mg)
  • indication &usage
    Treatment of erectile dysfunction(ED)
  • dosage &administration
    1. 1. One tablet (Mirodenafil 50mg or 100mg) recommended dosing frequency is once per day.
    2. 2. Taken orally approximately 60 minutes before sexual activity.
    3. 3. Sexual stimulation is required for a response to treatment.
  • characteristics
    1. 1. 89.04% of men with ED said they were satisfied with how well Mvix improved their erections.
    2. 2. Mvix is more selective PDE5 inhibitors with fewer PDE- related adverse effects
    3. 3. Mvix has Potent efficacy
      - IIEF EF domain 25.57 score
      - Normal erectile function recovery rate 62.2%

list